Each year, the virus kills a few hundred children younger than 5, and 6,000 to 10,000 seniors, according to the CDC. RSV also causes around 58,000 to 80,000 hospitalizations among children younger than 5 years old each year, the CDC said. Pfizer has said its maternal vaccine couldp...
"The recommendation that we received from the CDC advisors was one that was a more restrained recommendation than they typically deploy for their for their vaccine guidance," Dr. Jason Schwartz, an associate professor of health policy at the Yale School of Public Health, told ABC...
The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. The new guidan
CDC: RSV Vaccine Recommended for Older PeopleCENTERS for Disease Control & Prevention (U.S.)RESPIRATORY syncytial virus infection vaccinesOLDER peopledoi:10.1001/jama.2023.12537Harris, EmilyJAMA: Journal of the American Medical Association
[2]U.S. Centers for Disease Control and Prevention. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Seas...
More data is needed to determine whether these episodes may have been unrelated to the vaccine, according to the CDC. Dr. Sonja Rosen, section chief of geriatric medicine at Cedars-Sinai, recommends the RSV vaccine for older patients with lung disease, or for those who are otherwise ...
In 2022, nirsevimab, the first long-acting monoclonal antibody available for prevention of RSV in a broad infant population was licensed in the European Union and the United States, followed by a vaccine for elderly and maternal immunization in 2023 [24, 25]. In 2024, the German Standing ...
A person gets an influenza vaccine from a pharmacist during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center, on Sept. 9, 2022, in Chicago.Scott Olson/Getty Images, FILE CDC data shows flu vaccine coverage among all ...
[2]U.S. Centers for Disease Control and Prevention. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024. Mor...
来源:Vaccine前研 ✎我国科学家发现新冠病毒新血清型,为研发广谱新冠疫苗提供依据 中国科学院微生物研究所的团队发现新冠病毒变异株BA.2.86已演化成新血清型,这一发现对未来的疫苗和抗体研发具有重要意义。研究通过小鼠血清交叉中和分析,确定BA.2.86与现有XBB变异株的抗原性有明显区别,暗示基于XBB的疫苗可能无法充分抵...